Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase.
about
T6BP, a TRAF6-interacting protein involved in IL-1 signalingIRAK1b, a novel alternative splice variant of interleukin-1 receptor-associated kinase (IRAK), mediates interleukin-1 signaling and has prolonged stabilitySIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanismsInterleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosolToll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-betaEssential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunityPellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complexCD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cellsIRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinaseRole of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cellsTransactivation by the p65 subunit of NF-kappaB in response to interleukin-1 (IL-1) involves MyD88, IL-1 receptor-associated kinase 1, TRAF-6, and Rac1Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathwayIL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK)Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activationAct1, an NF-kappa B-activating proteinInterleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinaseThe role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption.Cell type- and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expressionThe TLR and IL-1 signalling network at a glanceTIRP, a novel Toll/interleukin-1 receptor (TIR) domain-containing adapter protein involved in TIR signalingNegative regulation of toll-like receptor-mediated signaling by TollipInhibition of interleukin-1beta -induced NF-kappa B activation by calcium/calmodulin-dependent protein kinase kinase occurs through Akt activation associated with interleukin-1 receptor-associated kinase phosphorylation and uncoupling of MyD88CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri.Dual Inhibition of Rip2 and IRAK1/4 Regulates IL-1β and IL-6 in Sarcoidosis Alveolar Macrophages and Peripheral Blood Mononuclear CellsInterleukin-1 receptor-associated kinase 2- and protein kinase D1-dependent regulation of IRAK-monocyte expression by CpG DNAThe murine IRAK2 gene encodes four alternatively spliced isoforms, two of which are inhibitoryFLN29, a novel interferon- and LPS-inducible gene acting as a negative regulator of toll-like receptor signalingInhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4Long-distance effects of insertional mutagenesisTNF and IL-1 exhibit distinct ubiquitin requirements for inducing NEMO-IKK supramolecular structuresMutant human cells with constitutive activation of NF-kappaBPhosphorylation of Ser24 in the pleckstrin homology domain of insulin receptor substrate-1 by Mouse Pelle-like kinase/interleukin-1 receptor-associated kinase: cross-talk between inflammatory signaling and insulin signaling that may contribute to inDynamic cross-talk analysis among TNF-R, TLR-4 and IL-1R signalings in TNFalpha-induced inflammatory responsesRoles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling.Mutagenesis by reversible promoter insertion to study the activation of NF-kappaB.The protein kinase PKR: a molecular clock that sequentially activates survival and death programs.The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activationModulation of Toll-interleukin 1 receptor mediated signaling.Kinase-active interleukin-1 receptor-associated kinases promote polyubiquitination and degradation of the Pellino family: direct evidence for PELLINO proteins being ubiquitin-protein isopeptide ligases.Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.
P2860
Q22254711-F3D816F0-D3F1-4D68-9FE8-3B787350AB8AQ24291311-E817AF7F-AEAC-4738-8133-9A131FB07ED7Q24301289-3684FA12-23FA-42D2-9BA8-436FB11B658FQ24307324-1B7359A4-1A60-4017-ADE1-F34EC38A01FDQ24311833-FF539896-3977-44DF-9C0F-A5B5A235A0C8Q24312889-F1F5B446-2417-4B25-921D-0EE7E92F1CB2Q24337456-AFA020F9-05DB-4430-9B5B-D43752D981D2Q24529963-1F22F346-C3E3-49F4-8FAF-B94EC25BE7AAQ24534145-0CB2E266-511D-4066-B8CC-AD061C78A231Q24534892-65CDBDB7-DBDD-4AC8-B67D-92D54EF70D9EQ24550930-E5FB63DC-703F-4749-9547-53C477719929Q24550984-8018BFD1-9779-48F9-BFDE-034DDABCBA3FQ24635274-68665494-D02C-44B7-AEF1-EB9E89F064AEQ24641992-11849F63-C91C-430D-A227-27AEB6578728Q24654030-29F3228B-2ED7-4A80-A8EC-2DE981C9C2B1Q24658087-17C39788-F5A2-4120-9737-3993AFB253DEQ24805207-48BDDA16-0CDC-4306-9818-C80C83C6657CQ27004287-091DEF9E-05BE-4B24-B8AE-3E23B3DC4589Q27013358-3FD18DBB-E16A-4DA2-9FCE-DD30B839ED19Q28201815-3EFF9CA8-AFF7-4211-BA6D-8B9EC0530437Q28212686-CDF9B808-0CA6-45C6-9628-38C47CD6DF3BQ28215796-3E4C0BF8-30D0-4536-8D4F-3F2C26C4EAD0Q28344579-5B2821C6-6F91-4ECF-BBD9-C91B32A294E2Q28385953-6FA9CFDE-095A-4B2C-BCA3-C359520F095AQ28482485-E1F4777C-6D2C-40B9-BFF3-A5D685FC1BE1Q28586277-A89C4011-5A93-429D-A005-E1D02DF44617Q28591863-3110074C-DD10-4FF7-B63E-0072DCB6F05FQ28611075-BD923E20-C0A6-4AFC-898F-05961243ACA6Q28743690-39E08C1E-FCC3-46A5-A420-E8CB6CDAB6B6Q30566060-419009C2-ED5D-413C-A4EE-2A5A05A21A0DQ31033964-345659DE-5BD4-47FE-84A0-0F36E811D35EQ31162696-85EBB9FB-2314-447E-B235-EFD882A07E1AQ33585802-85D0C26A-1F9B-429B-9E3D-8D4D8295F5E0Q33620139-A8AA2F2E-193B-4AB7-85A1-4CE6B58BE0D6Q33772184-0B0B841E-914D-48C2-A530-D49ADF4358F8Q34107642-5190F87C-C836-4935-965A-63A4A4C73441Q34462752-634C05CA-8716-408A-AD87-6C183F9ACF10Q34554357-557F5094-576E-4A86-80E6-457BA97B00B6Q34659316-5BEBE02F-AE81-4823-8C74-8E0B6A0A8136Q34789652-81888C9F-5D6B-4853-BA69-DF18CB70A540
P2860
Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mutant cells that do not respo ...... -1 receptor-associated kinase.
@ast
Mutant cells that do not respo ...... -1 receptor-associated kinase.
@en
type
label
Mutant cells that do not respo ...... -1 receptor-associated kinase.
@ast
Mutant cells that do not respo ...... -1 receptor-associated kinase.
@en
prefLabel
Mutant cells that do not respo ...... -1 receptor-associated kinase.
@ast
Mutant cells that do not respo ...... -1 receptor-associated kinase.
@en
P2093
P2860
P356
P1476
Mutant cells that do not respo ...... -1 receptor-associated kinase.
@en
P2093
P2860
P304
P356
10.1128/MCB.19.7.4643
P407
P577
1999-07-01T00:00:00Z